Vaxcyte, Inc. (PCVX) Misses Q2 EPS by 5c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($1.22), $0.05 worse than the analyst estimate of ($1.17).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nutrien warns shareholders about below-market mini-tender offer
• XORTX to voluntarily delist from TSX Venture Exchange